Your browser doesn't support javascript.
loading
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice.
Quarta, Carmelo; Stemmer, Kerstin; Novikoff, Aaron; Yang, Bin; Klingelhuber, Felix; Harger, Alex; Bakhti, Mostafa; Bastidas-Ponce, Aimee; Baugé, Eric; Campbell, Jonathan E; Capozzi, Megan; Clemmensen, Christoffer; Collden, Gustav; Cota, Perla; Douros, Jon; Drucker, Daniel J; DuBois, Barent; Feuchtinger, Annette; Garcia-Caceres, Cristina; Grandl, Gerald; Hennuyer, Nathalie; Herzig, Stephan; Hofmann, Susanna M; Knerr, Patrick J; Kulaj, Konxhe; Lalloyer, Fanny; Lickert, Heiko; Liskiewicz, Arek; Liskiewicz, Daniela; Maity, Gandhari; Perez-Tilve, Diego; Prakash, Sneha; Sanchez-Garrido, Miguel A; Zhang, Qian; Staels, Bart; Krahmer, Natalie; DiMarchi, Richard D; Tschöp, Matthias H; Finan, Brian; Müller, Timo D.
Afiliação
  • Quarta C; Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Stemmer K; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Novikoff A; University of Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France.
  • Yang B; Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Klingelhuber F; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Harger A; Molecular Cell Biology, Institute for Theoretical Medicine, University of Augsburg, Augsburg, Germany.
  • Bakhti M; Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Bastidas-Ponce A; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Baugé E; Division of Metabolic Diseases, Department of Medicine, Technical University of München, Munich, Germany.
  • Campbell JE; Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
  • Capozzi M; Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Clemmensen C; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Collden G; Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Cota P; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Douros J; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Drucker DJ; Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany.
  • DuBois B; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Feuchtinger A; Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany.
  • Garcia-Caceres C; Inserm, CHU Lille, Institute of Pasteur de Lille, European Genomic Institute for Genomics, University of Lille, Lille, France.
  • Grandl G; Department of Medicine, Division of Endocrinology, Duke University, Durham, NC, USA.
  • Hennuyer N; Department of Medicine, Division of Endocrinology, Duke University, Durham, NC, USA.
  • Herzig S; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hofmann SM; Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Knerr PJ; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Kulaj K; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Lalloyer F; Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany.
  • Lickert H; Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
  • Liskiewicz A; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
  • Liskiewicz D; Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
  • Maity G; Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  • Perez-Tilve D; Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Prakash S; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Sanchez-Garrido MA; Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
  • Zhang Q; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Staels B; Inserm, CHU Lille, Institute of Pasteur de Lille, European Genomic Institute for Genomics, University of Lille, Lille, France.
  • Krahmer N; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • DiMarchi RD; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
  • Tschöp MH; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Finan B; Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany.
  • Müller TD; Medical Clinic and Polyclinic IV, Ludwig-Maximilians University of München, Munich, Germany.
Nat Metab ; 4(8): 1071-1083, 2022 08.
Article em En | MEDLINE | ID: mdl-35995995
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: PPAR alfa / Diabetes Mellitus Tipo 2 Limite: Animals Idioma: En Revista: Nat Metab Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: PPAR alfa / Diabetes Mellitus Tipo 2 Limite: Animals Idioma: En Revista: Nat Metab Ano de publicação: 2022 Tipo de documento: Article